Search alternatives:
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
largest decrease » marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1241
Structural model outline.
Published 2025“…The data comes from a life evaluation question collected on nationally representative surveys covering 160 countries, conducted annually for 13 years. We take advantage of 40 years of variation in daily land surface temperature data, finding that one additional exceptionally hot day significantly lowers wellbeing, by roughly 0.5% on average. …”
-
1242
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer
Published 2025“…Furthermore, lactoperoxidase, malondialdehyde, and Fe(II) levels significantly increased in <b>12</b>-treated tissues, whereas superoxide dismutase concentrations decreased. …”
-
1243
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer
Published 2025“…Furthermore, lactoperoxidase, malondialdehyde, and Fe(II) levels significantly increased in <b>12</b>-treated tissues, whereas superoxide dismutase concentrations decreased. …”
-
1244
-
1245
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
-
1246
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
-
1247
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
-
1248
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
-
1249
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
-
1250
Graphical abstract regarding program development.
Published 2024“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
-
1251
Phases of the intervention program.
Published 2024“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
-
1252
Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO<sub>2</sub>/CH<sub>4</sub> Mixture Separation
Published 2024“…The field of flexible metal–organic frameworks (MOFs) has garnered significant attention from researchers due to their potential for gas storage and capture applications. …”
-
1253
Consort diagram.
Published 2024“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
-
1254
Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO<sub>2</sub>/CH<sub>4</sub> Mixture Separation
Published 2024“…The field of flexible metal–organic frameworks (MOFs) has garnered significant attention from researchers due to their potential for gas storage and capture applications. …”
-
1255
Characteristics of the sample.
Published 2024“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
-
1256
Baseline analysis, nominal factors.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1257
Minimal dataset for the study.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1258
Baseline analysis, continuous factors.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1259
Multivariable analysis between 2006 and 2018.
Published 2025“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
-
1260
General characteristics of study subjects.
Published 2025“…COVID-19 did not affect inpatient mortality (p = 0.9608), but in-hospital mortality decreased from 12% to 7% in the medical aid group.</p><p>Conclusion</p><p>Overall, we found that COVID-19 had an impact on admission rates of patients with AMI but did not have a significant impact on in-hospital mortality. …”